Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1975 Feb;37(2):105–114. doi: 10.1136/hrt.37.2.105

Hyperlipidaemia in children.

J K Lloyd
PMCID: PMC484091  PMID: 164201

Abstract

Hyperlipidaemia in children is most commonly expressed as hypercholesterolaemia. "Normal values" for serum cholesterol, if defined statistically, vary between communities, and levels of cholesterol in childhood above which an increased risk of coronary heart disease in adult life may be expected have not been firmly established. It is suggested that serum cholesterol concentration over 250 mg/dl (6.47 mmol/l) in a child over 1 year of age merits detailed investigation, including full lipoprotein analysis, and levels of serum cholesterol between230 and 250 mg/dl (5.95-6.47 mmol/l) should be repeated with further studies if indicated. Secondary hyperlipoproteinaemia rarely presents diagnostic problems but must always be excluded. The only primary hyperlipoproteinaemia likely to be encountered in childhood is familial hyperbetalipoproteinaemia in its common heterozygous form. The most effective means to date of lowering serum cholesterol in this condition is cholestyramine, but the long-term consequences of therapy are not known and treatment should at present be limited to children from high-risk families. Long-term follow-up is essential and until results of such studies are available population screening is unjustified.

Full text

PDF
105

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlson L. A., Böttiger L. E. Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study. Lancet. 1972 Apr 22;1(7756):865–868. doi: 10.1016/s0140-6736(72)90738-6. [DOI] [PubMed] [Google Scholar]
  2. Carter C. O., Slack J., Myant N. B. Genetics of hyperlipoproteinaemias. Lancet. 1971 Feb 20;1(7695):400–401. doi: 10.1016/s0140-6736(71)92238-0. [DOI] [PubMed] [Google Scholar]
  3. Chance G. W., Albutt E. C., Edkins S. M. Serum lipids and lipoproteins in untreated diabetic children. Lancet. 1969 Jun 7;1(7606):1126–1128. doi: 10.1016/s0140-6736(69)91645-6. [DOI] [PubMed] [Google Scholar]
  4. Darmady J. M., Fosbrooke A. S., Lloyd J. K. Prospective study of serum cholesterol levels during first year of life. Br Med J. 1972 Jun 17;2(5815):685–688. doi: 10.1136/bmj.2.5815.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Deutscher S., Ostrander L. D., Epstein F. H. Familial factors in premature coronary heart disease--a preliminary report from the Tecumseh Community Health Study. Am J Epidemiol. 1970 Mar;91(3):233–237. doi: 10.1093/oxfordjournals.aje.a121133. [DOI] [PubMed] [Google Scholar]
  6. Dietary and drug treatment of primary hyperlipoproteinemia. Ann Intern Med. 1972 Aug;77(2):267–294. doi: 10.7326/0003-4819-77-2-267. [DOI] [PubMed] [Google Scholar]
  7. Drash A., Hengstenberg F. The identification of risk factors in normal children in the development of arteriosclerosis. Ann Clin Lab Sci. 1972 Sep-Oct;2(5):348–359. [PubMed] [Google Scholar]
  8. ENOS W. F., HOLMES R. H., BEYER J. Coronary disease among United States soldiers killed in action in Korea; preliminary report. J Am Med Assoc. 1953 Jul 18;152(12):1090–1093. doi: 10.1001/jama.1953.03690120006002. [DOI] [PubMed] [Google Scholar]
  9. Fernandes J., Pikaar N. A. Hyperlipemia in children with liver glycogen disease. Am J Clin Nutr. 1969 May;22(5):617–627. doi: 10.1093/ajcn/22.5.617. [DOI] [PubMed] [Google Scholar]
  10. Glueck C. J., Fallat R., Buncher C. R., Tsang R., Steiner P. Familial combined hyperlipoproteinemia: studies in 91 adults and 95 children from 33 kindreds. Metabolism. 1973 Nov;23(2):1403–1428. doi: 10.1016/0026-0495(73)90256-4. [DOI] [PubMed] [Google Scholar]
  11. Glueck C. J., Heckman F., Schoenfeld M., Steiner P., Pearce W. Neonatal familial type II hyperlipoproteinemia: cord blood cholesterol in 1800 births. Metabolism. 1971 Jun;20(6):597–608. doi: 10.1016/0026-0495(71)90008-4. [DOI] [PubMed] [Google Scholar]
  12. Glueck C. J., Tsang R., Fallat R., Ford S., Jr, Evans G., Beckett D., Steiner P. Pediatric familial type IV hyperlipoproteinemia. Trans Assoc Am Physicians. 1972;85:139–150. [PubMed] [Google Scholar]
  13. Godfrey R. C., Stenhouse N. S., Cullen K. J., Blackman V. Cholesterol and the child: studies of the cholesterol levels of Busselton school children and their parents. Aust Paediatr J. 1972 Apr;8(2):72–78. doi: 10.1111/j.1440-1754.1972.tb01791.x. [DOI] [PubMed] [Google Scholar]
  14. JOYNER C. R., Jr, HORWITZ O., WILLIAMS P. G. The effect of lipemia upon tissue oxygen tension in man. Circulation. 1960 Nov;22:901–907. doi: 10.1161/01.cir.22.5.901. [DOI] [PubMed] [Google Scholar]
  15. Johnston I. D., Davis J. A., Moutafis C. D., Myant N. B. Ileal by-pass in the management of familial hypercholesterolaemia. Proc R Soc Med. 1967 Aug;60(8):746–748. doi: 10.1177/003591576706000816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kannel W. B., Castelli W. P., Gordon T., McNamara P. M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med. 1971 Jan;74(1):1–12. doi: 10.7326/0003-4819-74-1-1. [DOI] [PubMed] [Google Scholar]
  17. Kwiterovich P. O., Jr, Fredrickson D. S., Levy R. I. Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood. J Clin Invest. 1974 May;53(5):1237–1249. doi: 10.1172/JCI107670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lee V. A. Individual trends in the total serum cholesterol of children and adolescents over a ten-year period. Am J Clin Nutr. 1967 Jan;20(1):5–12. doi: 10.1093/ajcn/20.1.5. [DOI] [PubMed] [Google Scholar]
  19. Lloyd J. K. Control of dietary fat in relation to diabetic complications in children. Proc Nutr Soc. 1966;25(1):74–82. doi: 10.1079/pns19660014. [DOI] [PubMed] [Google Scholar]
  20. Lloyd J. K. Disorders of the serum lipoproteins. II. Hyperlipoproteinaemic states. Arch Dis Child. 1968 Oct;43(231):505–515. doi: 10.1136/adc.43.231.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. MASON J. K. ASYMPTOMATIC DISEASE OF CORONARY ARTERIES IN YOUNG MEN. Br Med J. 1963 Nov 16;2(5367):1234–1237. doi: 10.1136/bmj.2.5367.1234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. McNamara J. J., Molot M. A., Stremple J. F., Cutting R. T. Coronary artery disease in combat casualties in Vietnam. JAMA. 1971 May 17;216(7):1185–1187. [PubMed] [Google Scholar]
  23. Money for charity. Br Med J. 1969 Jul 5;3(5661):6–6. [PMC free article] [PubMed] [Google Scholar]
  24. Morris J. N., Kagan A., Pattison D. C., Gardner M. J. Incidence and prediction of ischaemic heart-disease in London busmen. Lancet. 1966 Sep 10;2(7463):553–559. doi: 10.1016/s0140-6736(66)93034-0. [DOI] [PubMed] [Google Scholar]
  25. Moutafis C. D., Myant N. B., Mancini M., Oriente P. Cholestyramine and nicotinic acid in the treatment of familial hyperbetalipoproteinaemia in the homozygous form. Atherosclerosis. 1971 Sep-Oct;14(2):247–258. doi: 10.1016/0021-9150(71)90054-2. [DOI] [PubMed] [Google Scholar]
  26. Patterson D., Slack J. Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives. Lancet. 1972 Feb 19;1(7747):393–399. doi: 10.1016/s0140-6736(72)90853-7. [DOI] [PubMed] [Google Scholar]
  27. Segall M. M., Fosbrooke A. S., Lloyd J. K., Wolff O. H. Carbohydrate-induced hypertriglyceridaemia in a child. Arch Dis Child. 1970 Feb;45(239):73–79. doi: 10.1136/adc.45.239.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Segall M. M., Fosbrooke A. S., Lloyd J. K., Wolff O. H. Treatment of familial hypercholesterolaemia in children. Lancet. 1970 Mar 28;1(7648):641–644. doi: 10.1016/s0140-6736(70)90884-6. [DOI] [PubMed] [Google Scholar]
  29. Seidel D., Agostini B., Müller P. Sturucture of an abnormal plasma lipoprotein (LP-X) characterizing obstructive jaundice. Biochim Biophys Acta. 1972 Jan 27;260(1):146–152. doi: 10.1016/0005-2760(72)90082-3. [DOI] [PubMed] [Google Scholar]
  30. Slack J. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet. 1969 Dec 27;2(7635):1380–1382. doi: 10.1016/s0140-6736(69)90930-1. [DOI] [PubMed] [Google Scholar]
  31. Starzl T. E., Putnam C. W., Chase H. P., Porter K. A. Portacaval shunt in hyperlipoproteinaemia. Lancet. 1973 Oct 27;2(7835):940–944. doi: 10.1016/s0140-6736(73)92599-3. [DOI] [PubMed] [Google Scholar]
  32. West R. J., Lloyd J. K. Use of cholestyramine in treatment of children with familial hypercholesterolaemia. Arch Dis Child. 1973 May;48(5):370–374. doi: 10.1136/adc.48.5.370. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES